编码版本

即将生效2026年10月1日 – 2027年9月30日

C69即将生效类别：需要更具体的编码

Malignant neoplasm of eye and adnexa

编码说明

Excludes 1

malignant neoplasm of connective tissue of eyelid (C49.0)
malignant neoplasm of eyelid (skin) (C43.1-, C44.1-)
malignant neoplasm of optic nerve (C72.3-)

更具体的编码

C69.0Malignant neoplasm of conjunctiva C69.1Malignant neoplasm of cornea C69.2Malignant neoplasm of retina C69.3Malignant neoplasm of choroid C69.4Malignant neoplasm of ciliary body C69.5Malignant neoplasm of lacrimal gland and duct C69.6Malignant neoplasm of orbit C69.8Malignant neoplasm of overlapping sites of eye and adnexa C69.9Malignant neoplasm of unspecified site of eye

账单与保险保障

何时必须使用ICD-10-CM

自2015年10月1日起，受HIPAA约束的美国诊断理赔必须使用ICD-10-CM。

门诊和专业服务理赔使用服务日期，住院理赔使用出院日期。此前的就诊使用ICD-9-CM；具体编码也必须在相应日期有效。

官方编码指南 → · CMS ↗

首次收录 · 2015-10-01

编码历史

自首次收录以来无变更记录

已变更无变更

FY2016

生效日期 2015-10-01

首次收录

Malignant neoplasm of eye and adnexa

类别 — 请选择更具体的编码

CDC/NCHS · FY2016

所有版本 (19)

所有版本	生效日期	编码历史
FY2016	2015-10-01	首次收录
FY2017	2016-10-01	分类表无变更
FY2018	2017-10-01	分类表无变更
FY2019	2018-10-01	分类表无变更
FY2020	2019-10-01	分类表无变更
FY2020 · April	2020-04-01	分类表无变更
FY2021	2020-10-01	分类表无变更
FY2021 · 01-01	2021-01-01	分类表无变更
FY2022	2021-10-01	分类表无变更
FY2022 · 04-01	2022-04-01	分类表无变更
FY2023	2022-10-01	分类表无变更
FY2023 · 04-01	2023-04-01	分类表无变更
FY2024	2023-10-01	分类表无变更
FY2024 · 04-01	2024-04-01	分类表无变更
FY2025	2024-10-01	分类表无变更
FY2025 · 04-01	2025-04-01	分类表无变更
FY2026	2025-10-01	分类表无变更
FY2026 · April	2026-04-01	分类表无变更
FY2027	2026-10-01	分类表无变更

编码说明

Excludes 1

malignant neoplasm of connective tissue of eyelid (C49.0)
malignant neoplasm of eyelid (skin) (C43.1-, C44.1-)
malignant neoplasm of optic nerve (C72.3-)

上级编码说明

章节 2 · Neoplasms (C00-D49)

Note

Functional activity
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
Morphology [Histology]
Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
Primary malignant neoplasms overlapping site boundaries
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
Malignant neoplasm of ectopic tissue
Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

更具体的编码

Malignant neoplasm of eye and adnexa

编码说明

更具体的编码

账单与保险保障

编码历史

所有版本 (19)

编码说明

上级编码说明

章节 2 · Neoplasms (C00-D49)

更具体的编码

相关编码

Malignant neoplasm of eye and adnexa

编码说明

更具体的编码

账单与保险保障

编码历史

所有版本 (19)

编码说明

上级编码说明

章节 2 · Neoplasms (C00-D49)

更具体的编码

相关编码